Effects of bosentan on peripheral endothelial function in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension

Abstract. Endothelin receptor antagonists (ERAs) have been shown to improve the prognosis of patients with pulmonary arterial hypertension (PAH). However, the effect of the oral dual ERA bosentan on peripheral endothelial dysfunction (PED), as assessed by flow-mediated vasodilation (FMD), in patient...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Pulm Circ
Asıl Yazarlar: Hirashiki, Akihiro, Adachi, Shiro, Nakano, Yoshihisa, Kamimura, Yoshihiro, Shimokata, Shigetake, Takeshita, Kyosuke, Murohara, Toyoaki, Kondo, Takahisa
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: University of Chicago Press 2016
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4869920/
https://ncbi.nlm.nih.gov/pubmed/27252842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/685715
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller